Modern nephrology has moved away from the outdated textbook rule of “start dialysis at creatinine 707 μmol/L (8 mg/dL).” This change reflects medicine’s shift toward personalized treatment decisions rather than rigid numerical thresholds.
Why was this standard removed?
- Creatinine is imperfect: While important, it’s an unreliable standalone marker of kidney function
- Misses complications: Doesn’t reflect critical clinical factors like:
- Fluid overload
- Electrolyte imbalances
- Uremic symptoms
- Risk of mistiming: Strict adherence could mean:
- Starting too late (when complications are severe)
- Starting too early (wasting residual kidney function)
Current Best Practices
The KDIGO guidelines (global gold standard for kidney care) define ESRD at eGFR 15 (≈ creatinine 400-500) but emphasize:
❗ “ESRD diagnosis ≠ automatic dialysis indication”
Three Key Considerations Before Dialysis:
- Complication severity: Are symptoms life-threatening or manageable medically?
- Reversible factors: Could treatment recover some function? (e.g., infections, obstruction)
- Medication response: How well are current therapies working?
A Cautionary Case Study: Mr. Wang from Jiangsu
History: 12-year CKD patient, started dialysis at creatinine 623 μmol/L
Outcome: After comprehensive treatment addressing reversible factors:
- Discontinued dialysis within months
- Creatinine stabilized at 70-76 μmol/L (near normal)
Lessons from This Case:
- Don’t rush to dialysis just because creatinine is “high”
- Assess treatable factors first
- Preserve residual function – premature dialysis can accelerate its loss
When Dialysis Might Be Premature
Red flags suggesting unnecessary dialysis:
- Creatinine 500-600 without severe symptoms
- Stable condition on medications
- Potential reversible contributors present
Remember: The removal of the “707 rule” was meant to enable better care – not lower standards. Each case deserves thoughtful evaluation.
Key Adaptations for U.S. Audience:
- Measurement Units: Included both μmol/L and mg/dL (standard in U.S. practice)
- Guideline Context: Highlighted KDIGO as the authoritative source
- Clinical Terms: Used “eGFR” alongside creatinine for familiarity
- Case Presentation: Framed as a teachable moment rather than criticism
- Visuals: Maintained original author image for credibility
This version preserves all medical nuances while making the content accessible to English-speaking patients and providers. Let me know if you’d like any adjustments for your specific audience.
发表回复